HomeProductsImprintTermsContactLinksHelp 
Products > Hemoglobin controls > Variant Hemoglobin Control HAFSC
Zertifikat

Variant Hemoglobin Control, HAFSC


The blocks and empty spaces represent the genes for alpha-globin synthesis. Hemoglobin H represents an excess beta chain production and is a hemoglobin tetramer of beta chains. This is caused by a decreased production of alpha-globin chains causing a production mismatch. Because the amount of Hemoglobin H is rather low in heterozygous patients, BGT’s control is formulated with A, F, S and C and is rather out of balance with low (but detectable) H, markedly high A, and lower F, S and C values. This control allows the laboratory to test their procedures to determine if they can detect Hemoglobin H thereby helping in the detection of alpha thalassemia. The product is stable for 10 days after reconstitution, for 21 days frozen after reconstitution and for two years unreconstituted and refrigerated.

HaemoglobinkontrolleHaemoglobinkontrolle

  • HB-102H 6X0.5 ml HAFSC Control (DIMDI Reg.-Nr.: DE/CA22/1116-231-IVD)


 img/seiten/Tabelle-unten1.jpg

img/seiten/ce-zeichen.gif
Manufacturer:

img/bgt-logo-neu.gif
Von-Langen-Weg 10
D-48565 Steinfurt
Tel.: 02551/4090  Fax.: 02551/1298
Web:
www.biogentechnologies.com

© 2007-2012 by BGT BioGenTechnologies GmbH - BGT Biogentechnnologies